A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Public ClinicalTrials.gov record NCT06373146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Study identification
- NCT ID
- NCT06373146
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 392 participants
Conditions and interventions
Conditions
Interventions
- Mibavademab Drug
- Mibavademab-Placebo Drug
- Tirzepatide Drug
- Tirzepatide-Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2024
- Primary completion
- Dec 14, 2025
- Completion
- Apr 1, 2026
- Last update posted
- May 5, 2026
2024 – 2026
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research, Gardena | Gardena | California | 90247 | — |
| Irvine Clinical Research | Irvine | California | 92614 | — |
| Velocity Clinical Research, Los Angeles | Los Angeles | California | 90017 | — |
| Velocity Clinical Research, North Hollywood | North Hollywood | California | 91606 | — |
| Velocity Clinical Research, Santa Ana | Santa Ana | California | 92704 | — |
| Velocity Clinical Research, Panorama City | Van Nuys | California | 91405 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Velocity Clinical Research - New Orleans | New Orleans | Louisiana | 70119 | — |
| Hassman Research Institute Marlton Site | Marlton | New Jersey | 08053 | — |
| Lillestol Research | Fargo | North Dakota | 58104 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| South Texas Clinical Research | Corpus Christi | Texas | 78404 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Juno Research | Houston | Texas | 77040 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06373146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06373146 live on ClinicalTrials.gov.